Grapefruit Could Soon be Safe to Eat with Medication, Thanks to New Research
Grapefruit is known for its numerous health benefits, but it can also interact dangerously with certain medications, either enhancing their effects to dangerous levels or rendering them ineffective. However, recent research offers a potential solution to this problem.
The culprit behind these interactions is a group of compounds known as furanocoumarins found in grapefruit. These compounds interfere with over 100 prescription drugs, leading to warnings for people on these medications to avoid certain fruits like grapefruit.
A team of researchers from The Volcani Center in Israel set out to identify the genes responsible for producing furanocoumarins in grapefruit and pomelo. They discovered a multi-gene cluster in the 2-oxoglutarate-dependent dioxygenase (2OGD) family that is responsible for producing these compounds as a defense mechanism.
With this new knowledge, the possibility of genetically engineering grapefruits and pomelos without furanocoumarins is now within reach. Unlike grapefruits and pomelos, other citrus fruits like oranges and mandarins do not naturally produce these compounds.
Through a combination of DNA and RNA analysis, gene comparisons, and cross-breeding experiments, the researchers identified different genes within the 2OGD cluster responsible for furanocoumarin production in various parts of the plant and under different conditions.
Further investigation revealed that a specific DNA sequence known as the 655-base insertion sequence disrupts the activity of the gene responsible for furanocoumarin production in citrus fruits that do not contain these compounds. This genetic variation may have evolved over time in these plants.
While the researchers did not create furanocoumarin-free grapefruits in this study, they have laid the groundwork for future research and development in this area. The goal is to produce citrus varieties that are safe for consumption by individuals taking prescription medications, thereby preventing potentially harmful drug interactions.
The findings of this research have been published in New Phytologist, offering hope for a future where grapefruits can be enjoyed without the risk of medication interference.
